{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-009065","form_type":"8-K","ticker":"NASC","cik":"0001509957","company_name":"Can B Corp","filed_at":"2024-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.426810+00:00","generated_at":"2026-06-05T02:35:34.725276+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Can B Corp. subsidiary Nascent Pharma acquires two cannabis liquid formulation patents valued at $122M","bullets":["Nascent Pharma, 67% owned by Can B, acquired US patents 9,730,911 and 10,555,928 covering liquid cannabis formulations including beverages, tinctures, vape pens, and capsules.","Independent 2020 valuation set patent value at $122M, applying a 90% discount on projected income streams through August 2034.","Nascent agreed to pay prior patent owner's creditors 5% of Can B's share of Nascent revenues until aggregate $10M paid.","Consulting agreement with inventor entitles consultant to 50% of distributions Can B receives from Nascent.","Can B warns no assurance patents will generate revenue or achieve the $122M valuation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-009065","json":"https://secwatch.observer/filing/0001493152-24-009065.json","markdown":"https://secwatch.observer/filing/0001493152-24-009065.md","text":"https://secwatch.observer/filing/0001493152-24-009065.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1509957/000149315224009065/0001493152-24-009065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1509957/000149315224009065/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T02:35:34.725276+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}